Nug Avenue has picked up more than 10,000 new unique members as of the end of June, significantly exceeding initial projections Sugarmade has opened an escrow account for the purpose of acquiring property in California to be used for delivery hub SGMD has taken steps toward making an offer on licenses for the state of Oregon A growing cannabis delivery…
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has announced that it will release its fiscal year 2021 financial report at the end of the week. INM’s full financial statements and related MD&A for the period ending June 30, 2021, will be released on Friday, Sept. 24, 2021. In connection with the release…
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator of proprietary patented drug-delivery platform DehydraTECH(TM), recently released partial results from human clinical study HYPER-H21-1. The study evaluated DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension/high blood pressure. “The partial results showed that blood pressure was reduced across both male and female volunteers; it was more pronounced with DehydraTECH-CBD in the study’s…
Lexaria Bioscience has developed a patented technology that improves the bioavailability of pharmaceuticals and therapeutics in part by bypassing first-pass-liver processing Lexaria’s patented DehydraTECH (TM) technology is undergoing human clinical trials this year to determine its effectiveness in making cannabidiol (“CBD”) effective as a means of reducing blood pressure for high blood pressure patients The initial results of the first…
$58.5 million in Adjusted Sales for first six months of 2021 The company also reported repaying approximately $18 million of debt and restructuring over $20 million into a long-term debt Q2 also marked RWB’s acquisition of Acreage Florida, as well as an operational 45,000 SF greenhouse within the state, which it projects, will begin harvesting in Q4 2021 RWB’s CEO…
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has reported its second quarter 2021 financials. The report includes the news that adjusted sales for the first six months reached $58.5 million, with revenue for Q2 2021 topping $13.3 million compared to $11.8 million in Q1 2021, an increase of 13%. The…
CALGARY, August 25, 2021 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (TSXV:HITI) (Nasdaq:HITI) (FSE:2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, announced today that the Company will release its financial and operational results for the quarter ended July 31, 2021 after market close on Tuesday, September 14, 2021. High Tide’s third…
Lexaria Bioscience is a drug delivery technology innovator whose flagship technology, DehydraTECH(TM), provides a means of enhancing substances’ delivery time to increase their effectiveness without adverse effects A new podcast by NetworkNewsAudio highlights DehydraTECH’s successes in trials that measure blood pressure reduction using DehydraTECH-enhanced CBD in comparison with generic controls The DehydraTECH technology is also being analyzed for effectiveness in…
Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of cannabis-derived products and brands, has reported financial and operating results for the six-month period ending June 30, 2021. Highlights of the report include revenue of more than $2 million with an estimated unaudited gross profit of 60% as compared to revenues of approximately $100,000 for 2020, operating expenses of $6…
Clinical study HYPER-H21-1 evaluates the use of patented DehydraTECH(TM)-processed CBD for use against hypertension Hypertension is a primary or contributing factor in the death of almost 500,000 people per year, with approximately one in four adults aged 20 to 44 suffering from high blood pressure Initial results of the study show that blood pressure was reduced in both male and…
Red White & Bloom released its Q4 2020 and FY 2020 results and later reported its Q1 2021 results In its Q4 2020 results, the company posted a 158% quarter-over-quarter increase in revenue from $CA6.1 million in Q3 2020 to $15.7 million Its FY revenue grew from nil in 2019 to CA$23.3 million in 2020, while its gross profit was…
Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH…